The features of coronavirus disease in pregnant women and the frequency of perinatal complications depending on the severity of the course of this disease




coronavirus disease, pregnant women, extragenital pathology, complications of pregnancy


Purpose - to analyze clinical and laboratory changes in women with mild to moderate coronavirus disease, the frequency of gestational complications depending on the course of the disease.

Materials and methods. 120 pregnant women of the main group with coronavirus disease were involved in the clinical and laboratory examination. The control group consisted of 40 women with gestational age from 22 to 41 weeks, whose pregnancy was not complicated by coronavirus disease.

The course of the disease and the impact of coronavirus infection on the course of pregnancy were evaluated by the results of general - clinical, laboratory and instrumental examinations.

Results. The surveyed women underwent treatment in the period from 2021 to 2022 at the Communal Non-profit Enterprise «Kyiv City Center for Reproductive and Perinatal Medicine».

The mild course of disease had 48 (40%) pregnant women, the course of coronavirus disease of moderate severity had 72 (60%) pregnant women.

Symptoms of coronavirus disease observed in pregnant women: hyperthermia - body t≥37.0oC (85 (70.8%) women), general weakness (103 (85.8%) women), loss of smell and taste (27 (22.5%) women), catarhal phenomena (69 (57.5%) women).

Decrease in saturation to 92-94% was noted at 18 (15%) pregnant women.

The following complications of pregnancy were observed: the threat of premature birth, oligohydramnios, polyhydramnios, fetal growth retardation, structural changes in the placenta according to ultrasound examination of the fetus, violation of fetal-placental blood flow I-II centuries.

Conclusions. Given the data of the analysis, it is possible to identify certain features of clinical and laboratory manifestations of coronavirus disease. The most common clinical manifestations are hyperthermia and general weakness. Features of changes in laboratory blood parameters are as follows: leukopenia, lymphocytopenia, increased C-reactive protein and D-dimer, decreased activated partial thromboplastin time, increased prothrombin time, increased total fibrinogen. The most common complications in pregnant women with mild to moderate coronavirus disease: the risk of premature birth, structural changes of the placenta and oligohydramnios.

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies.

No conflict of interests was declared by the author.

Author Biography

A.V. Balan, Shupyk National Healthcare University of Ukraine, Kyiv

CNE «Kyiv City Center for Reproductive and Perinatal Medicine», Ukraine


Alfaraj SH, Al-Tawfiq JA, Memish ZA. (2019). Middle East Respiratory Syndrome Coronavirus (MERS- CoV) infection during pregnancy: Report of two cases & review of the literature. J Microbiol Immunol Infect. 52 (3): 501-503.; PMid:29907538 PMCid:PMC7128238

Boelig RC, Manuck T, Oliver EA, Mascio DD, Saccone G, Bellussi F, Berghella V. (2022). Labor and Delivery Guidance for COVID-19. Jefferson University, Philadelphia, USA, University of North Carolina-Chapel Hill and UNC Health, Chapel Hill, NC, USA, Sapienza University of Rome, Italy School of Medicine, University of Naples Federico II, Naples, Italy.

Breslin N. (2020). COVID-19 in pregnancy: early lessons. Am J Obstet Gynecol. 2: 100-111.

Breslin N. (2020). COVID-19 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol. MFM. 2: 100-118.; PMid:32838266 PMCid:PMC7308019

Di Mascio D, Khalil A, Saccone G et al. (2020). Outcome of Coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM.

Docherty AB, Harrison EM, Green CA et al. (2020). Features of 16749 hospitalised UK patients with COVID-19 using the ISARIC WHO clinical characterisation protocol.

Doria A, Iaccarino L, Arienti S et al. (2006). Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol. 22 (2): 234-241.; PMid:16704920

Guan WJ, Ni ZY, Hu Y. (2020). Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 382 (18): 1708-1720.; PMid:32109013 PMCid:PMC7092819

Jin JM et al. (2020). Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health: 8.; PMid:32411652 PMCid:PMC7201103

Liu Y, Chen H, Tang K, Guo Y. (2020). Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect.; PMCid:PMC7133645

Rasmussen SA, Jamieson DJ, Macfarlane K et al. (2009). PandemicInfluenza and Pregnancy Working Group. Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health. 99 (2): S248-S254.; PMid:19461110 PMCid:PMC4504360

Statement on the second meeting of the International Health Regulations. (2005). Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) 30 January 2020 Statement Geneva, Switzerland.

Vallejo V, Ilagan JG. (2020). A postpartum death due to Coronavirus disease 2019 (COVID-19) in the United States. Obstet Gynecol. 136 (1): 52-55.; PMid:32384387

WHO. (2020). Coronavirus disease 2019 (COVID-19). Situation Report, 23.

Wu C. (2020). Clinical manifestation and laboratory characteristics of SARS-CoV-2 infection in pregnant women. Virol Sin. 35: 305-310.; PMid:32314274 PMCid:PMC7167538

Yan J, Guo J, Fan C. (2020). Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol. 223 (1): 111.e1-111.e14.; PMid:32335053 PMCid:PMC7177142

Zaigham M, Andersson O. (2020). Maternal and perinatal outcomes withCOVID19: a systematic review of 108 pregnancies. Acta Obstet GynecolScand.; PMid:32259279 PMCid:PMC7262097